Conference/Events
| ShowHide Related Items >><< - 01/11/21
- AC Immune, Biogen rise after Lilly reports Alzheimer's study met endpoint
- 01/11/21
- Biogen study to develop biomarkers of cognitive health using Apple devices
- 01/08/21
- Biogen treats first patient in RESPOND study of SPINRAZA
- 01/05/21
- Biogen, ViGeneron enter collaboration agreement to develop gene therapy products
CBIO Catalyst Biosciences - 12/07/20
- Catalyst Biosciences presents Crimson 1 Phase 3 study design
- 12/02/20
- Catalyst Biosciences receives FDA fast track designation for MarzAA
- 10/14/20
- Catalyst Biosciences receives patent for anti-complement Factor 3 portfolio
- 01/14/21 Truist
- Truist says FDA wouldn't be discussing label if not going to approve aducanumab
- 01/11/21 Goldman Sachs
- Eli Lilly's Alzheimer's trial data a 'positive surprise,' says Goldman Sachs
- 12/04/20 Mizuho
- Sage Therapeutics upgraded to Buy from Neutral at Mizuho
- 12/01/20 Truist
- Sage Therapeutics price target raised to $70 from $60 at Truist
CBIO Catalyst Biosciences - 12/02/20 Raymond James
- Catalyst Biosciences gets Fast Track for MarzAA, says Raymond James
- 05/21/20 Raymond James
- Catalyst Biosciences initiated with an Outperform at Raymond James
- 10/21/20
- Biogen cuts FY20 adjusted EPS view to $32.50-$33.50 from $34.00-$36.00
- 10/21/20
- Biogen reports Q3 adjusted EPS $8.84, consensus $8.13
- 10/20/20
- Notable companies reporting before tomorrow's open
- 10/20/20
- Notable companies reporting before tomorrow's open
CBIO Catalyst Biosciences - 11/05/20
- Catalyst Biosciences reports Q3 EPS (73c), consenus (81c)
- 08/06/20
- Catalyst Biosciences reports Q2 EPS (96c), consenus (86c)
|
On The Fly
| ShowHide Related Items >><< - 09:01 Today
- JPMorgan: Overall pipeline for 2021 remains robust, expects M&A to be active
- 08:48 Today
- JPMorgan sees investment banking fees up 'modestly' in Q1
- 08:47 Today
- JPMorgan sees NII about $55.5B in 2021
- 08:37 Today
- JPMorgan doesn't see meaningful increase in charge-offs until at least 2H21
- 12:03 Today
- Citi sees value in simplifying company
- 11:54 Today
- Citi sees peak U.S. loss rates in 1H22
- 11:47 Today
- Citi says reserve release reflects economic outlook
- 11:37 Today
- Citi plans to resume buybacks in Q1
- 12:05 Today
- OCC fines former Wells Fargo general counsel $3.5M in settlement
- 10:36 Today
- Wells Fargo: 'Significant amount of work to do' before asset cap can be lifted
- 10:34 Today
- Wells Fargo: 1% of possible 2021 NII decline tied to student loan sale
- 10:29 Today
- Wells Fargo: Loan demand remains weak overall
- 11:22 Today
- PNC Financial targeting mid-year close for BBVA US transaction
- 11:07 Today
- PNC Financial expects to resume share repurchases in 2H21
- 08:04 Today
- PNC Financial sees 'stable' revenue in FY21 vs. FY20
- 08:04 Today
- PNC Financial sees Q1 net interest income down approximately 1%
- 12/30/20
- Exxon Mobil identifies factors that may impact Q4 earnings
- 12/11/20
- Exxon Mobil discovers hydrocarbons at Sloanea-1 exploration well
- 11/30/20
- Exxon Mobil to take $17B-$20B in impairment charges in Q4
- 11/30/20
- Exxon Mobil estimates $16B-$19B in 2021 CAPEX, to prioritize high-value assets
- 01/14/21
- Accolade jumps almost 13% after announcing acquiring 2nd.MD
- 01/14/21
- Accolade confirms to acquire 2nd.MD for $460M
- $324.63 /
-17.59 (-5.14%) - 01/11/21
- Spotify Kids adds Shared Playlists feature
- 12/17/20
- Spotify to launch in South Korea in first half of 2021
- 12/15/20
- Spotify announces partnership with Duke, Duchess of Sussex's Archewell Audio
- 12/02/20
- Spotify up 11% to $316.83 in afternoon trading
- 05:36 Today
- DBV Technologies gets feedback from FDA regarding Viaskin Peanut regulatory path
- 01/07/21
- DBV Technologies restructuring plan to result in reduction of over 200 jobs
- 11/24/20
- DBV Technologies CSO Hugh Sampson to step down from role
- 11/02/20
- DBV Technologies receives validation for Viaskin Peanut MAA by EMA
- 08:04 Today
- Bionano Genomics announces presentations from Cytogenomics Symposium
- 01/14/21
- Bionano Genomics announces presentations from Cytogenomics Symposium
- 01/13/21
- Bionano Genomics announces presentations from Cytogenomics Symposium
- 01/12/21
- Bionano Genomics announces presentations from Cytogenomics Symposium
- 08:18 Today
- Cardiff Oncology presents data from Phase 1b/2 study in KRAS-mCRC
- 12/06/20
- Cardiff Oncology presents updated data from Phase 1b/2 study in R/R AML
- 10/20/20
- Cardiff Oncology reports new data from Phase 2 trial of onvansertib
- 09/17/20
- Cardiff Oncology presents data on onvansertib in colorectal cancer
- 01/05/21
- Goodbody implements Progress Sitefinity Cloud management system
- 12/21/20
- Progress Software, Ingram Micro expand partnership agreement
- 11/11/20
- The Royal British Legion selects Progress Sitefinity for digital experience
- 10/27/20
- Danville Area School District implements Progress WhatsUp Gold
- 01/11/21 Piper Sandler
- JPMorgan price target raised to $150 from $118 at Piper Sandler
- 01/07/21
- Fly Intel: Top five analyst upgrades
- 01/07/21 Jefferies
- JPMorgan upgraded to Buy with $152 price target at Jefferies
- 01/07/21 BofA
- JPMorgan upgraded to Buy from Neutral at BofA
- 01/12/21 UBS
- UBS downgrades Citizens on revenue headwinds, Wells new top pick
- 01/11/21 Piper Sandler
- Citi price target raised to $85 from $68 at Piper Sandler
- 01/11/21 BofA
- BofA US 1 List changes
- 01/06/21 Deutsche Bank
- Citi price target raised to $58 from $50 at Deutsche Bank
- 01/12/21 UBS
- UBS downgrades Citizens on revenue headwinds, Wells new top pick
- 01/11/21 UBS
- Wells Fargo upgraded to Buy from Neutral at UBS
- 01/07/21 Jefferies
- Wells Fargo upgraded to Buy with $38 price target at Jefferies
- 01/07/21 Jefferies
- Wells Fargo upgraded to Buy from Hold at Jefferies
- 01/13/21 Piper Sandler
- PNC Financial downgraded to Neutral from Overweight at Piper Sandler
- 01/11/21 Citi
- PNC Financial upgraded to Buy from Neutral at Citi
- 01/11/21 Citi
- PNC Financial upgraded to Buy from Neutral at Citi
- 01/06/21 Deutsche Bank
- PNC Financial price target raised to $157 from $115 at Deutsche Bank
- 01/14/21 Barclays
- Barclays upgrades Exxon to Overweight amidst 'perfect storm'
- 01/14/21 Barclays
- Exxon Mobil upgraded to Overweight from Equal Weight at Barclays
- 01/13/21
- Fly Intel: Top five analyst upgrades
- 01/13/21 JPMorgan
- JPMorgan announces top 10 energy picks for 2021
- 08:54 Today BTIG
- Accolade price target raised to $60 from $55 at BTIG
- 07:08 Today Baird
- Accolade price target raised to $55 from $50 at Baird
- 06:23 Today Credit Suisse
- Accolade upgraded to Outperform from Neutral at Credit Suisse
- 05:17 Today Credit Suisse
- Accolade upgraded to Outperform from Neutral at Credit Suisse
- $324.63 /
-17.59 (-5.14%) - 09:52 Today
- Fly Intel: Top five analyst downgrades
- 06:39 Today Citi
- Citi cuts Spotify to Sell with no benefit seen on podcast investments
- 05:46 Today Citi
- Spotify downgraded to Sell from Neutral at Citi
- 01/04/21 Barclays
- Spotify assumed with an Overweight at Barclays
- 06:42 Today Citi
- DBV Technologies price target raised to $8 from $4 at Citi
- 06:10 Today H.C. Wainwright
- DBV now has 'clear developmental path,' says H.C. Wainwright
- 11/02/20 Societe Generale
- DBV Technologies upgraded to Hold on improved visibility at Societe Generale
- 11/02/20 Societe Generale
- DBV Technologies upgraded to Hold from Sell at Societe Generale
- 12/04/20 Roth Capital
- Bionano Genomics downgraded to Neutral from Buy at Roth Capital
- 12/04/20 Roth Capital
- Bionano Genomics downgraded to Neutral from Buy at Roth Capital
- 09/24/20 Ladenburg
- Bionano Genomics initiated with a Buy at Ladenburg
- 04/08/20 Oppenheimer
- Oppenheimer bullish on Bionano Genomics, initiates with an Outperform
- 10/22/20
- Fly Intel: Top five analyst initiations
- 10/22/20 H.C. Wainwright
- Cardiff Oncology initiated with a Buy at H.C. Wainwright
- 10/21/20 Maxim
- Cardiff Oncology price target raised to $20 from $14 at Maxim
- 10/08/20
- Fly Intel: Top five analyst initiations
- 08/26/20 Wedbush
- Progress Software assumed with an Outperform at Wedbush
- 06/26/20 Benchmark
- Progress Software price target raised to $43 from $39 at Benchmark
- 01/17/20 Benchmark
- Progress Software price target raised to $57 from $49 at Benchmark
- 06:55 Today
- JPMorgan reports Q4 EPS $3.79, consensus $2.62
- 01/14/21
- Notable companies reporting before tomorrow's open
- 01/14/21
- Notable companies reporting before tomorrow's open
- 01/14/21
- Fly Intel: What to watch in first round of big bank earnings reports
- 12:00 Today
- Citi sees FY21 revenue down mid-to-high single digits, consensus $70.04B
- 11:56 Today
- Citi sees FY21 decline in net interest revenues $1B-$2B
- 08:05 Today
- Citi reports Q4 EPS $2.08, consensus $1.34
- 01/14/21
- Notable companies reporting before tomorrow's open
- 08:07 Today
- Wells Fargo reports Q4 EPS 64c, consensus 60c
- 01/14/21
- Notable companies reporting before tomorrow's open
- 01/14/21
- Notable companies reporting before tomorrow's open
- 01/14/21
- Fly Intel: What to watch in first round of big bank earnings reports
- 06:55 Today
- PNC Financial reports Q4 EPS $3.26, consensus $2.61
- 01/14/21
- Notable companies reporting before tomorrow's open
- 01/14/21
- Notable companies reporting before tomorrow's open
- 11/16/20
- PNC Financial expects acquisition of BBVA subsidiary to be 21% accretive in 2022
- 12/30/20
- Exxon Mobil says Q4 income boosted by up to $600M from gas prices
- 10/30/20
- Exxon Mobil reports Q3 ex-items EPS (18c), consensus (25c)
- 10/29/20
- Notable companies reporting before tomorrow's open
- 10/29/20
- Notable companies reporting before tomorrow's open
- 01/07/21
- Accolade sees FY21 revenue $162M-$165M, consensus $159.78M
- 01/07/21
- Accolade sees Q4 revenue $51M-$54M, consensus $51.6M
- 01/07/21
- Accolade reports Q3 EPS (32c), consensus (35c)
- 10/14/20
- Accolade raises FY21 revenue view to $159M-$162M from $158M-$161M
- $324.63 /
-17.59 (-5.14%) - 10/29/20
- Spotify sees Q4 revenue EUR 2B-EUR 2.2B, total MAUs 340M-345M
- 10/29/20
- Spotify reports Q3 EPS (EUR 0.58) vs. EUR 0.36 last year
- 10/28/20
- Notable companies reporting before tomorrow's open
- 10/28/20
- Notable companies reporting before tomorrow's open
- 07/31/20
- DBV Technologies reports first half EPS EUR (1.62) vs. EUR (2.43) last year
- 11/12/20
- Bionano Genomics reports Q3 revenue $2.2M, consensus $2.07M.
- 10/15/20
- Bionano Genomics sees Q3 revenue $1.9M-$2.3M, consensus $2.07M
- 08/13/20
- Bionano Genomics reports Q2 net loss ($8.0M) vs. ($7.67M) a year ago
- 11/05/20
- Cardiff Oncology reports Q3 EPS (19c), consensus (19c)
- 01/14/21
- Progress Software sees FY21 EPS $3.22-$3.28, two estimates $3.21
- 01/14/21
- Progress Software reports Q4 EPS 91c, two estimates 77c
- 09/29/20
- Progress Software reports Q3 EPS 78c, consensus 77c
- 09/08/20
- Progress raises FY20 non-GAAP EPS view to $2.94-$2.97 from $2.82-$2.86
|
Hot Stocks
| ShowHide Related Items >><< - 10:36 Today
- Wells Fargo: 'Significant amount of work to do' before asset cap can be lifted
- 10:34 Today
- Wells Fargo: 1% of possible 2021 NII decline tied to student loan sale
- 10:29 Today
- Wells Fargo: Loan demand remains weak overall
- 10:24 Today
- Wells Fargo no longer offering Covid deferrals, except in home lending, CFO says
- 01/12/21 UBS
- UBS downgrades Citizens on revenue headwinds, Wells new top pick
- 01/11/21 UBS
- Wells Fargo upgraded to Buy from Neutral at UBS
- 01/07/21 Jefferies
- Wells Fargo upgraded to Buy with $38 price target at Jefferies
- 01/07/21 Jefferies
- Wells Fargo upgraded to Buy from Hold at Jefferies
- 08:07 Today
- Wells Fargo reports Q4 EPS 64c, consensus 60c
- 01/14/21
- Notable companies reporting before tomorrow's open
- 01/14/21
- Notable companies reporting before tomorrow's open
- 01/14/21
- Fly Intel: What to watch in first round of big bank earnings reports
- 01/14/21
- Wells Fargo close to deal for asset management business, Reuters reports
- 01/14/21
- Wells Fargo in talks to sell asset management unit to buyout firms, Reuters says
- 12/22/20
- Tech companies win as SEC permits direct IPOs for cash raise, Bloomberg says
- 12/22/20
- Wells Fargo satisfied consent order requirements, American Banker reports
- 09:02 Today
- Fly Intel: Pre-market Movers
- 01/12/21
- NIO downgrade, Wells Fargo upgrade among today's top calls on Wall Street
- 01/06/21
- Fly Intel: Pre-market Movers
- 12/15/20
- Fly Intel: Wall Street's top stories for Tuesday
- 01/12/21
- Unusually active option classes on open January 12th
- 11/24/20
- Unusual call flow in option market yesterday
- 11/23/20
- Call butterfly sale in Wells Fargo might adjust positions
- 11/19/20
- Notable open interest changes for November 19th
|